Pelago and AstraZeneca enter CETSA research collaboration
27 November 2015 | By
Pelago and AstraZeneca will together develop assay formats and applications of the CETSA method relevant across the range of AstraZeneca’s therapeutic areas...
List view / Grid view
News
Scientists successfully combine antibody-drug conjugates with immunotherapy
26 November 2015 | By Victoria White
Researchers from the University of Basel have, for the first time, successfully combined an antibody-drug conjugate with a therapy that stimulates the immune system to attack breast cancer cells...
Scientists create therapeutic venom database
26 November 2015 | By Victoria White
Venom Knowledge Base summarises the results of 5,117 studies in the medical literature describing the use of venom toxins as painkillers and as treatments for diseases...
Gene map identifies genes unique to different cancers
26 November 2015 | By Victoria White
Scientists from the University of Toronto have switched off, one by one, almost 18,000 genes - 90% of the entire human genome - to find the genes that are essential for cell survival...
ReproCELL acquires Scottish life sciences company Biopta
25 November 2015 | By Victoria White
The transaction, expected to complete next month, is aimed at strengthening ReproCELL’s pharmaceutical industry-targeted drug discovery services...
Allergan and Rugen to develop ASD and OCD therapies
25 November 2015 | By Victoria White
Rugen has already demonstrated efficacy for its compounds in animal models of ASD and OCD...
Ablynx and Novo Nordisk in Nanobody drug discovery collaboration
25 November 2015 | By
Ablynx and Novo Nordisk hope to discover and develop novel multi-specific drug candidates using Ablynx's proprietary Nanobody technology...
Teva and Heptares to develop treatments for migraine
25 November 2015 | By Victoria White
The companies have entered an agreement to discover and develop novel, small-molecule CGRP antagonists for the treatment of migraine...
Scientists use X-ray crystallography to see pneumolysin
24 November 2015 | By Victoria White
Pneumolysin is associated with deadly infections such as bacterial pneumonia, meningitis and septicaemia...
UCL launches gene therapy company Athena Vision
24 November 2015 | By Kate Douetil
UCL has announced the formation of Athena Vision, a biopharmaceutical company focused on developing gene therapies for eye diseases...
LSP and Bristol-Myers Squibb team up for life sciences innovation
24 November 2015 | By Victoria White
The companies have said they will focus is on immuno-oncology, one of the hottest and most dynamic areas in biotechnology...
TSRI scientists reveal potential treatment for dangerous viral infections
23 November 2015 | By Victoria White
Scientists have shown how a previously unknown process works to promote infection in a number of dangerous viruses, including dengue, West Nile and Ebola...
A drug that heals broken bones faster and better
23 November 2015 | By Victoria White
Using bone samples from people undergoing hip replacement surgery, researchers were able to show that a drug that activates the Wnt pathway causes stem cells found within bones to divide and to turn into more bone cells...
£1 billion fund set up to fight malaria and other infectious diseases
23 November 2015 | By Victoria White
The Ross Fund includes £115 million to develop new drugs, diagnostics and insecticides for malaria, TB and other infectious disease resistance...
Evgen expands pipeline with novel compounds
23 November 2015 | By Victoria White
Evgen has said it will use its Sulforadex platform to synthesise and stabilise the newly acquired compounds with a view to taking the most promising into clinical development...
